The Biohacking Index has released its January 2026 Report, marking a significant shift to an invite-only expert model that prioritizes physician curation over sponsorship or popularity. The report, available at biohackingindex.com, is the first to be curated exclusively by invited clinicians, reinforcing the platform's commitment to credibility and evidence-based evaluation in the wellness and biohacking ecosystem.
Under the new model, the Biohacking Index evaluates companies based on transparency, documentation, and real-world clinical relevance. Verification remains optional for Premium Members, but the platform now operates an invite-only membership for clinicians and expert providers. Physicians are selected based on clinical experience, patient outcomes, professional reputation, and alignment with evidence-based, forward-thinking care.
Invited experts may nominate wellness technologies, diagnostics, or nutraceuticals they actively use or recommend. They can also nominate their own solutions, provided those products complete the full Biohacking Index verification process. Expert members receive enhanced professional profiles, SEO and large language model training benefits, and lead generation capabilities within the platform. However, nomination does not guarantee inclusion, and verification remains optional but the standard for credibility.
The January 2026 report highlights three verified companies: Da Vinci Medical, a manufacturer of advanced recovery and wellness technologies including the SUPERHUMAN Protocol; Lumati, a light-based wellness technology company focused on cellular signaling and recovery; and Truista Coffee, a functional coffee company emphasizing contaminant transparency and third-party lab testing. Each company met Biohacking Index standards for transparency, documentation, and practitioner relevance.
Physician curation is led by Dr. Lipman, founder of Physical Evidence Chiropractic in Boca Raton, Florida, known for integrating advanced diagnostics, regenerative therapies, and recovery technologies. With over 100 five-star patient reviews and recognition as a Top 10 Provider in the 2025 Biohacking Index Report, his nominations reflect tools used in active clinical practice. Several additional companies were nominated but elected not to pursue verification, and these nominations remain visible to reflect practitioner awareness while maintaining transparency around verification status.
The January 2026 report signals a broader industry shift toward expert-led evaluation, voluntary verification, and clear separation between recommendation and endorsement. As the report states, "Being recommended is not the same as being verified. And verification remains an open door, not a requirement." The full report is available at biohackingindex.com.
